Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CDC25B phosphorylation by p38 and MK-2.

Matthieu Lemaire1, Carine Froment, Rose Boutros

  • 1LBCMCP-CNRS UMR5088-IFR109, Institut d'Exploration Fonctionnelle des Génomes, Université Paul Sabatier, Toulouse, France.

Cell Cycle (Georgetown, Tex.)
|July 25, 2006
PubMed
Summary

This study clarifies how MAPKAP kinase-2 and p38SAPK phosphorylate CDC25B, a key phosphatase in cell cycle regulation. Findings reveal specific phosphorylation sites and their cellular localization, highlighting the complexity of in vivo phosphorylation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Healthcare system complexity of hepatitis B and C related liver disease: service mapping in New South Wales, Australia.

Frontiers in health services·2026
Same author

Impacts of hepatitis B and C prevention programmes on long-term outcomes of advanced liver disease and hepatocellular carcinoma: A systematic review.

Public health·2026
Same author

A RiboCancer cell line panel reveals that CLL-associated Rps15 mutations translationally rewire transcription through codon-specific tRNA accommodation defects.

HemaSphere·2026
Same author

Palliative Care Admission at End-of-Life in Liver Cancer: A 10 Year Population-Based Study of 3565 Deaths in Australia.

Cancer medicine·2026
Same author

Economic evaluations of the primary prevention programs for viral hepatitis-related liver disease and liver cancer: a systematic literature review.

Cost effectiveness and resource allocation : C/E·2026
Same author

Targeting p38α in cancer: challenges, opportunities, and emerging strategies.

Molecular oncology·2026

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • CDC25B is a human phosphatase crucial for cyclin-dependent kinase activation and cell cycle control.
  • It plays a role in regulating entry into mitosis and DNA damage response.
  • Previous research on CDC25B phosphorylation by p38SAPK and MAPKAP kinase-2 was controversial.

Purpose of the Study:

  • To clarify the specific kinases responsible for CDC25B phosphorylation.
  • To identify the phosphorylation sites on CDC25B.
  • To investigate the cellular localization of phosphorylated CDC25B.

Main Methods:

  • Utilized mass spectrometry to identify phosphorylation sites.
  • Employed specific antibodies against phosphorylated CDC25B residues.

Related Experiment Videos

  • Analyzed CDC25B localization during the cell cycle.

    • Main Results:

    • MAPKAP kinase-2 phosphorylates CDC25B at multiple sites (S169, S323, S353, S375).
    • p38SAPK phosphorylates CDC25B at S249.
    • The S323-phosphorylated form of CDC25B localizes to the centrosome during the cell cycle.

    Conclusions:

    • MAPKAP kinase-2 and p38SAPK are confirmed kinases for CDC25B phosphorylation.
    • The study identifies specific phosphorylation sites and centrosomal localization of CDC25B.
    • Characterizing in vivo phosphorylation patterns is complex due to multiple kinase interactions.